Literature DB >> 16798474

Diabetic microvascular complications--can the presence of one predict the development of another?

Aniz Girach1, Louis Vignati.   

Abstract

The number of people with diabetes is increasing dramatically worldwide. The rising prevalence of obesity in childhood and adolescence has also been linked to a startling increase in the number of diagnosed cases of type 2 diabetes in these younger age groups. Despite the introduction of treatment strategies, diabetes remains a major cause of new-onset blindness, end-stage renal disease, and lower leg amputation, all of which contribute to the excess morbidity and mortality in people with diabetes. Furthermore, the management of diabetes-related complications generates substantial costs. In order that timely treatment can be given, it is essential that patients at risk for the development of diabetic microvascular complications are identified earlier. Diabetes duration and glycemic, blood pressure, and lipid control have consistently been shown to correlate with diabetic retinopathy, neuropathy, and nephropathy, but to date, the relationship of one diabetic microvascular complication to another has not been clearly described. A review of the literature has raised the question that apart from other known risk factors, there is a possible relationship among the diabetic microvascular complications themselves, and this appears to be much stronger than the sparse published data on it would suggest. A scoring system that can predict the development of diabetic microvascular complications may facilitate the early identification of those patients at risk and, consequently, have a positive impact on patients' quality of life and reduce the economic burden of diabetes and its complications.

Entities:  

Mesh:

Year:  2006        PMID: 16798474     DOI: 10.1016/j.jdiacomp.2006.03.001

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  39 in total

Review 1.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

2.  31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients.

Authors:  S F E Praet; H M M De Feyter; R A M Jonkers; K Nicolay; C van Pul; H Kuipers; L J C van Loon; J J Prompers
Journal:  MAGMA       Date:  2006-12-19       Impact factor: 2.310

3.  Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Authors:  Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengul; Onder Us; Kubilay Karsidag
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

4.  [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

Authors:  F Ziemssen; K Lemmen; B Bertram; H P Hammes; H Agostini
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

5.  The Prevention and Treatment of Retinal Complications in Diabetes.

Authors:  Susanne Gabriele Schorr; Hans-Peter Hammes; Ulrich Alfons Müller; Heinz-Harald Abholz; Rüdiger Landgraf; Bernd Bertram
Journal:  Dtsch Arztebl Int       Date:  2016-12-02       Impact factor: 5.594

6.  Ischemic diabetic retinopathy as a possible prognostic factor for chronic kidney disease progression.

Authors:  W J Lee; L Sobrin; M H Kang; M Seong; Y J Kim; J-H Yi; J W Miller; H Y Cho
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

7.  Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.

Authors:  Meijian Guan; Jun Ma; Jacob M Keaton; Latchezar Dimitrov; Poorva Mudgal; Mary Stromberg; Jason A Bonomo; Pamela J Hicks; Barry I Freedman; Donald W Bowden; Maggie C Y Ng
Journal:  Hum Genet       Date:  2016-07-26       Impact factor: 4.132

8.  Diabetic polyneuropathy, deep white matter lesions, and carotid atherosclerosis: is there any association?

Authors:  Sevgi Ferik; Hayat Güven; Mehlika Panpallı Ateş; Işık Conkbayır; Selçuk Çomoğlu; Bülent Güven
Journal:  Neurol Sci       Date:  2017-10-23       Impact factor: 3.307

Review 9.  Genetic susceptibility of diabetic retinopathy.

Authors:  Shrena Patel; Haoyu Chen; Nicholas H Tinkham; Kang Zhang
Journal:  Curr Diab Rep       Date:  2008-08       Impact factor: 4.810

Review 10.  Angiotensin blockade to reduce microvascular damage in diabetes mellitus.

Authors:  Roland E Schmieder; Stephan Martin; Gabriele E Lang; Peter Bramlage; Michael Böhm
Journal:  Dtsch Arztebl Int       Date:  2009-08-24       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.